GSK962040 (HCl salt)(923565-22-4)
- Name: GSK962040 (HCl salt)
- Synonyms:GSK962040 (HCl salt);Camicil hydrochloride;GSK962040 (hydrochloride);GSK962040 hydrochloride (Camicinal hydrochloride
- Molecular Formula:C25H34ClFN4O
- Molecular Weight:461.023
- CAS Registry Number:923565-22-4
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.923565-22-4 GSK962040 (HCl salt)
Assay:99% Transportation:By sea Application:Pharmaceutical industry
Min. Order:0
Supplier:Antimex Chemical Limied [
China (Mainland)] CAS No.923565-22-4 GSK962040 (HCl salt)
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.923565-22-4 GSK962040 (HCl salt)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:GSK962040 (HCl salt)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.923565-22-4 GSK962040 hydrochloride
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.923565-22-4 GSK 962040 hydrochloride
Assay:>98% Appearance:Solid powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:GSK 962040 hydrochloride is the hydrochloride form of GSK 962040, which is a selective motilin receptor agonist with pEC50 value of 7.9. It may be used as a treatment in diabetic gastroparesis. It...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 174671-46-6/5-FLUOROBENZO[C][1,2]OXABOROL-1(3H)-OL
- 872044-70-7/AN-0128
- 906673-24-3/5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole
- 747412-64-2/AUY 922
- 902240-76-0/Cyclohexanepropanoic acid, 3-[(4-chlorophenyl)sulfonyl]-3-(2,5-difluorophenyl)-, (1R,3R)-rel-
- 902240-86-2/MK-0752
- 850140-72-6/Afatinib
- 1028486-01-2/MLN-8237
- 1094042-01-9/2-(4-(5-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanolhydrochloride
- 1056636-07-7/CYT387,MsOH salt
- 1056636-06-6/CYT387 2H2SO4 salt
- 1056634-68-4/Momelotinib
- 847157-12-4/Hexanamide, 2-[[[(4S)-17-[methyl(methylsulfonyl)amino]-2-oxo-3-azatricyclo[13.3.1.16,10]eicosa-1(19),6,8,10(20),15,17-hexaen-4-yl]methyl]amino]-N-(2-methylpropyl)-, (2S)-
- 1093486-14-6/rac D-205 Dye
- 918333-06-9/Benzamide, 3,5-dichloro-N-[[(3S,4R)-1-(3,3-dimethylbutyl)-3-fluoro-4-piperidinyl]methyl]-
- 357606-66-7/(R)-ONO-AE2-227
- 357606-68-9/(S)-ONO-AE2-227
- 357605-73-3/ONO-AE2-227
- 380472-84-4/1-Piperazinamine, 4-(9H-fluoren-9-yl)-N-[3-(2-furanyl)-2-propen-1-ylidene]-
- 923565-22-4/GSK962040 (HCl salt)
- 923565-21-3/GSK962040
- 1023276-09-6/8-(2,3-dihydro-1H-inden-5-yl)-N-methoxy-2-(4-(1-methylpiperidin-4-yl)phenylamino)-5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxamide
- 319463-51-9/AG13736
- 918505-58-5/PLX-0728
- 870483-87-7/5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine
- 1116652-18-6/Cyclohexanecarboxamide, N-[2-[(3,4-dichlorophenyl)amino]-4-quinolinyl]-
- 1118460-77-7/UCPH-101
- 1001617-78-2/2-Pyrrolidinecarboxamide, N-[1,1'-biphenyl]-2-yl-2-methyl-1-[3-(1-methyl-1H-benzimidazol-2-yl)-1-oxopropyl]-, (2S)-
- 1010389-82-8/Pyrazolo[4,3-c]azepine-5(1H)-acetamide, 4-[2-(3,5-difluoro-4-methylphenyl)ethyl]-1-ethyl-4,6,7,8-tetrahydro-N,3-dimethyl-α-phenyl-, (αR,4S)-
- 1036401-99-6/Imidazo[1,5-a]pyrazine-7(8H)-acetamide, 8-[2-(3,4-dimethylphenyl)ethyl]-3-ethyl-5,6-dihydro-1-methoxy-N-methyl-α-phenyl-, (αR,8R)-